September 18, 2013

Two organizations are providing an educational program centered on a serious form of arthritis that affects up to 2 million people in the United States.

September 18, 2013

The Arthritis Society is donating more than C$4.5 million for arthritis research in Canada, the group said Wednesday.

September 9, 2013

Minister of Health Rona Ambrose joined with Domenic Pilla, Shoppers Drug Mart president and CEO, on Monday in the launch of the company's Arthritis Screening program — a way for Canadians to work with a pharmacist to help detect arthritis early and manage their condition.

September 6, 2013

Expanding pharmacists' role in Canada could reduce the burden of chronic illness on patients and save the country's healthcare system between C$1.4 billion and C$1.9 billion (US$1.34 billion-$1.83 billion) over the next three years, according to a new report released by Arthritis Consumer Experts, the Arthritis Research Centre of Canada and Shoppers Drug Mart.

Canada's single-payer healthcare system is vastly different from that of the United States, not to mention differences between the two countries in terms of laws and regulations that govern pharmacy, but the lessons from the study apply equally to both.

September 4, 2013

Expanding the role of pharmacists in Canada is one solution that will reduce the burden of chronic illness on patients, and save the system an estimated C$1.4 billion to C$1.9 billion dollars over three years, according to a new report released by Arthritis Consumer Experts, the Arthritis Research Centre of Canada and Shoppers Drug Mart.

August 28, 2013

The results of a large survey of patients with rheumatoid arthritis have been published, the company that conducted the survey said Wednesday.

August 6, 2013

Hospira posted sales of $1 billion during second quarter 2013, a 0.7% decrease compared with second quarter 2012, the generic drug maker said.

July 2, 2013

Arthritis is one of the most common chronic illnesses in children, but it often goes unnoticed and undiagnosed, according to two arthritis-focused organizations seeking to spread awareness about the disease.

May 10, 2013

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

April 30, 2013

The Food and Drug Administration has approved a drug made by Genentech for a rare form of arthritis in children, the company said Tuesday.

April 8, 2013

An experimental drug developed by AstraZeneca for rheumatoid arthritis produced mixed results in measurements of patients' conditions, according to results of a late-stage clinical trial.

April 2, 2013

Specialty drugs are expected to account for 50% of all drug costs by 2018, according to two new studies.

March 25, 2013

More than 400 drugs are under development for the 10 most common chronic health conditions affecting elderly people, according to a new report by a drug industry trade group.

December 18, 2012

A new product makes gripping such things as eating utensils, pens and toothbrushes easier for people with arthritis.

December 6, 2012

Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat active psoriatic arthritis, the company said Thursday.

November 13, 2012

Patients with a form of arthritis that affects young people taking a drug made by Abbott experienced improvements in their condition after a year of treatment, according to late-stage clinical trial results.

November 6, 2012

The Food and Drug Administration has approved a drug for rheumatoid arthritis ahead of the day the agency was scheduled to decide whether or not to approve it, the agency said Tuesday.

October 17, 2012

Vitamin D supplementation could be considered an immunomodulatory agent for systemic lupus erythematosus, an autoimmune disease characterized not only by skin, joint, neurological and renal symptoms, but also by inflammation of tissue linings in the body, according to a new clinical study published Tuesday in BioMedCentral's open access journal Arthritis Research and Therapy.

October 12, 2012

The Food and Drug Administration has approved a new use for a drug made by Roche division Genentech.

October 9, 2012

The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said.

September 28, 2012

The Food and Drug Administration has approved a drug made by Abbott for treating ulcerative colitis.

September 19, 2012

A subsidiary of Johnson & Johnson is hoping to gain Food and Drug Administration approval for a new formulation of one of its drugs.

August 29, 2012

A panel of outside advisers to the Food and Drug Administration has backed wider use for Abbott Labs’ rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease.

August 23, 2012

A division of Johnson & Johnson has started a late-stage clinical trial program for a drug for rheumatoid arthritis under a partnership with British drug maker GlaxoSmithKline.